James Goodrich
Impact in
- Virology top 0.5%
- HIV Research and Treatment
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
- Antifungal resistance and susceptibility
Papers in
- Virology 12
- HIV Research and Treatment 12
-
- HIV/AIDS drug development and treatment 6
- HIV/AIDS Research and Interventions 5
- Co-authors
- Howard Mayer (8 shared papers)Elna van der Ryst (4 shared papers)Roy M. Gulick (4 shared papers)John F. Sullivan (2 shared papers)Nathan Clumeck (2 shared papers)Bonaventura Clotet (2 shared papers)Jacob Lalezari (2 shared papers)Anders Karlsson (1 shared paper)
- Journals
- JAIDS Journal of Acquired Immune Deficiency Syndromes (5 papers)The Journal of Infectious Diseases (2 papers)HIV Clinical Trials (2 papers)Clinical Therapeutics (2 papers)Journal of the International AIDS Society (2 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
James Goodrich
30 papers receiving 1.8k citations
James Goodrich's Hit Papers
Peers
Comparison fields: 5 of 79
- Virology 956
- Infectious Diseases 846
- Emergency Medicine 140
- Epidemiology 464
- Hepatology 68
Countries citing papers authored by James Goodrich
This map shows the geographic impact of James Goodrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Goodrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Goodrich more than expected).
Fields of papers citing papers by James Goodrich
This network shows the impact of papers produced by James Goodrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Goodrich. The network helps show where James Goodrich may publish in the future.
Co-authors
The 25 scholars most cited alongside James Goodrich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Maraviroc for Previously Treated Patients with R5 HIV-1 Infection Hit paper breakdown → | 2008 | 591 |
| 2 | 2005 | 229 | |
| 3 | 1990 | 183 | |
| 4 | 2016 | 122 | |
| 5 | 2009 | 114 | |
| 6 | 1997 | 104 | |
| 7 | 2010 | 73 | |
| 8 | 2010 | 62 | |
| 9 | 2010 | 51 | |
| 10 | 2011 | 43 | |
| 11 | 2010 | 39 | |
| 12 | Ganciclovir three times per week is not adequate to prevent cytomegalovirus reactivation after T cell-depleted marrow transplantation. | 1994 | 34 |
| 13 | 2013 | 32 | |
| 14 | 2012 | 25 | |
| 15 | 2013 | 17 | |
| 16 | 2013 | 16 | |
| 17 | 2010 | 15 | |
| 18 | 2008 | 15 | |
| 19 | 1995 | 14 | |
| 20 | Adoptive immunotherapy of human cytomegalovirus infection: potential role in protection from disease progression. | 1991 | 14 |
About James Goodrich
James Goodrich is a scholar working on Virology, Infectious Diseases, Epidemiology, Emergency Medicine and Surgery, having authored 32 papers that have together received 1.9k indexed citations. Recurring topics across this work include HIV Research and Treatment (12 papers), HIV/AIDS drug development and treatment (6 papers), HIV/AIDS Research and Interventions (5 papers), Cytomegalovirus and herpesvirus research (3 papers), Fungal Infections and Studies (2 papers), Herpesvirus Infections and Treatments (2 papers), Mycobacterium research and diagnosis (2 papers) and HIV-related health complications and treatments (2 papers). The work is most often cited by research in Virology (956 citations), Infectious Diseases (846 citations), Emergency Medicine (140 citations), Epidemiology (464 citations) and Hepatology (68 citations). James Goodrich has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Howard Mayer, Elna van der Ryst, Roy M. Gulick, John F. Sullivan, Nathan Clumeck, Bonaventura Clotet, Jacob Lalezari, Anders Karlsson, Edwin DeJesus and Michael Wohlfeiler. Their work appears in journals such as JAIDS Journal of Acquired Immune Deficiency Syndromes, The Journal of Infectious Diseases, HIV Clinical Trials, Clinical Therapeutics and Journal of the International AIDS Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.